NCT05178576 2022-11-04
A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
NSABP Foundation Inc
Phase 2 Withdrawn
NSABP Foundation Inc
New Hope Medical Center
SWOG Cancer Research Network